Universität Des Saarlandes

This study is testing if adding a pill called lenvatinib to an existing immunotherapy drug (pembrolizumab) works better than the immunotherapy alone to keep cancer from coming back. It's for adults with a specific type of advanced head and neck cancer who have just finished their…